Radiation-induced fibrosis treatment
AssigneeHandelsselskabet af 20.10.2020 ApS
InventorJens Steen OLSEN
Life of this patent
Estimating the term…
Abstract
Disclosed herein is a pharmaceutical composition for use in the treatment or prevention of radiation-induced fibrosis, wherein the composition comprises an extract of Trigonella foenum-graecum and optionally pharmaceutically acceptable additives.
Claims22
1-21. (canceled)
22-56. (canceled)
A pharmaceutical composition for use in the treatment or prevention of radiation-induced fibrosis, wherein the composition comprises an extract of Trigonella foenum-graecum and optionally pharmaceutically acceptable additives.
A method of treatment or prevention of radiation-induced fibrosis comprising topical application of Trigonella extract foenum-graecum, such as in the form of a gel, cream, ointment or spray and/or oral administration of Trigonella foenum-graecum extract, such as in the form of a plaster, throat lozenge, or tablet.
Dependencies are inferred from the claim text.